INTERNATIONAL PATENT: TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED, 泰励生物科技（上海）有限公司 FILES APPLICATION FOR "DUAL-PAYLOAD ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, March 16 -- TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED (5/F, Building 1B, 3728 Jinke RoadPudong New Area, Shanghai 201203), 泰励生物科技（上海）有限公司 (中国上海市浦东新区金科路3728号1号楼B栋5层) filed a patent application (PCT/CN2025/118931) for "DUAL-PAYLOAD ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Sep 04, 2025. With publication no. WO/2026/051996, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...